Article Versions Notes

Liu W, Yao F, Wang J, Shao N, Cao X, Dong Z, Zhang B, Sun X. Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation. Biomedicines. 2025; 13(6):1315. https://doi.org/10.3390/biomedicines13061315

Liu, Wenxiu, Fan Yao, Jinghan Wang, Nan Shao, Xinxin Cao, Zhengqi Dong, Bin Zhang, and Xiaobo Sun. 2025. "Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation" Biomedicines 13, no. 6: 1315. https://doi.org/10.3390/biomedicines13061315

Liu, W., Yao, F., Wang, J., Shao, N., Cao, X., Dong, Z., Zhang, B., & Sun, X. (2025). Combination Therapy of Half-Dose Resmetirom and Metformin Attenuates Metabolic Dysfunction-Associated Steatohepatitis Through Improving Cholesterol Metabolism and Inflammation. Biomedicines, 13(6), 1315. https://doi.org/10.3390/biomedicines13061315